Gilles R. Dagenais
Lung Institute(US)Université Laval(CA)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Lipoproteins and Cardiovascular Health, Cardiovascular Function and Risk Factors, Diabetes, Cardiovascular Risks, and Lipoproteins, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,888 cited
- → Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease(2017)2,369 cited
- → Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study(2019)1,888 cited
- → World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions(2019)1,132 cited
- → Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality(2005)1,110 cited
- → Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study